Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Pairwise analyses of T-RFLP community profilesa

From: Non-therapeutic administration of a model antimicrobial growth promoter modulates intestinal immune responses

  Day / Group
  3 8 14 21
Treatment Comparisons A B A B A B A B
Control (A) vs CTC (B) 0.797 0.021* 0.025* 0.732 0.338 0.542 0.308 0.267
Control (A) vs CR (B) 0.908 0.423 0.023* 0.441 0.570 0.547 0.181 0.151
Control (A) vs CTC+CR (B) 0.807 0.024* 0.053 0.153 0.298 0.599 0.059 0.063
CTC (A) vs CR (B) 0.193 0.633 0.508 0.269 0.808 0.691 0.058 0.065
CTC (A) vs CTC+CR (B) 0.827 0.593 0.738 0.127 0.698 0.746 0.212 0.218
CR (A) vs CTC+CR (B) 0.416 0.042* 0.227 0.008* 0.450 0.653 0.057 0.052
  1. aP values marked with an asterisk are significantly different (P = 0.05).